Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes

Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes

Objective: The clinical cases of patients with multisystem inflammatory syndrome (MIS-C) were analyzed via a systematic review and meta-analysis of the clinical findings, treatments, and possible outcomes of articles retrieved via database searches. Sources: The authors searched the PubMed, Scielo,...

Full description

Bibliographic Details
Main Authors:	Mônica O. Santos, Lucas C. Gonçalves, Paulo A.N. Silva, André L.E. Moreira, Célia R.M. Ito, Fernanda A.O. Peixoto, Isabela J. Wastowski, Lilian C. Carneiro, Melissa A.G. Avelino
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	Jornal de Pediatria
Subjects:	MIS-C PIMS-TS COVID-19 SARS-CoV-2 Children
Online Access:	http://www.sciencedirect.com/science/article/pii/S0021755721001480

Similar Items

The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis
by: Mohamad Hamad Saied, et al.
Published: (2023-08-01)

B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C)
by: Adam Klocperk, et al.
Published: (2023-10-01)

Approach to a child with Multisystem Inflammatory Syndrome associated with COVID19. Recommendations by the Polish Paediatric Society Expert Group. Update – February 2021
by: Magdalena Okarska-Napierała, et al.
Published: (2021-07-01)

Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Treated with Tocilizumab
by: Carmen Niño-Taravilla, et al.
Published: (2020-12-01)

Pediatric inflammatory multisystem syndrome temporally associated with COVID-19 – a novel condition in children and adolescents
by: Małgorzata Wieteska, et al.
Published: (2021-07-01)

Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS)
by: Susanna Felsenstein, et al.
Published: (2020-10-01)

Elevated risk for psychiatric outcomes in pediatric patients with Multisystem Inflammatory Syndrome (MIS-C): A review of neuroinflammatory and psychosocial stressors
by: Tracy Pan, et al.
Published: (2024-07-01)

Polymorphism of clinical manifestations, experience of diagnosis and treatment of multisystem inflammatory syndrome associated with COVID-19 in children
by: L.V. Pypa, et al.
Published: (2022-12-01)

Review of available therapies for the treatment of pediatric COVID-19-associated polyarticular inflammatory syndrome
by: Michał Leśniewski
Published: (2024-02-01)

Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later
by: Megan Striha, et al.
Published: (2021-11-01)

Role of Lung Ultrasonography (LUS) as a Tool for Evaluating Children with Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS)
by: Jolanta Tomczonek-Moruś, et al.
Published: (2023-04-01)

Editorial: Multisystem inflammatory syndrome in children
by: Angela Mauro, et al.
Published: (2024-03-01)

Multisystem inflammatory syndrome in children associated with Bacille Calmette-Guérin scar: a case presentation
by: Hilal Kizildag, et al.
Published: (2023-03-01)

Case Report: Changes in Cytokine Kinetics During the Course of Disease in a Japanese Patient With Multisystem Inflammatory Syndrome in Children
by: Satoshi Takasago, et al.
Published: (2021-07-01)

Is It Inflammatory Bowel Disease Flare or Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19?
by: Paulina Krawiec, et al.
Published: (2022-05-01)

“Multisystem Inflammatory Syndrome in Children”-Like Disease after COVID-19 Vaccination (MIS-V) with Potential Significance of Functional Active Autoantibodies Targeting G-Protein-Coupled Receptors (GPCR-fAAb) for Pathophysiology and Therapy
by: Marius Schmidt, et al.
Published: (2023-11-01)

Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health
by: Megan S. Rafferty, et al.
Published: (2021-04-01)

Manifestations of the pediatric multisystem inflammatory syndrome temporally related with SARS-CoV-2 (PIMS) in the gastrointestinal, cardiovascular, nervous and respiratory systems.
by: Anna Brzyska, et al.
Published: (2022-04-01)

A tendency to worse course of multisystem inflammatory syndrome in children with obesity: MultiOrgan Inflammatory Syndromes COVID-19 related study
by: Aneta Monika Gawlik, et al.
Published: (2022-09-01)

Successful Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 (PIMS-TS) with Split Doses of Immunoglobulin G and Estimation of PIMS-TS Incidence in a County District in Southern Germany
by: Götz Wehl, et al.
Published: (2021-04-01)

Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study)
by: Lorena Acevedo, et al.
Published: (2021-11-01)

Gastrointestinal manifestations of COVID-19-associated multisystem inflammatory response syndrome in children
by: І. Yu. Avramenko, et al.
Published: (2022-05-01)

Eastern India Collaboration on Multisystem Inflammatory Syndrome in Children (EICOMISC): A Multicenter Observational Study of 134 Cases
by: Snehamayee Nayak, et al.
Published: (2022-03-01)

Association of Ethnicity With Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2 Infection: An International Case-Referent Study
by: Judith G. Middelburg, et al.
Published: (2021-10-01)

Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome
by: Piotr Buda, et al.
Published: (2022-09-01)

Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome
by: Danilo Buonsenso, et al.
Published: (2020-09-01)

The Youngest Palestinian Case of Multisystem Inflammatory Syndrome in children (MIS-C)
by: Fawzy Mazen Abunejma, et al.
Published: (2022-12-01)

Anakinra in pediatric acute fulminant myocarditis
by: Louise Maunier, et al.
Published: (2022-08-01)

Short-term and medium-term clinical outcomes of multisystem inflammatory syndrome in children: a prospective observational cohort study
by: Anastasia Glazyrina, et al.
Published: (2024-01-01)

Case report: Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 with severe myocardial dysfunction. Is there any hope in immunotherapy?
by: Julita Tokarek, et al.
Published: (2023-05-01)

Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children – a cross-sectional observational study from southern India.
by: Aishwarya Venkataraman, et al.
Published: (2021-04-01)

Multisystem inflammatory syndrome in children: A systematic review
by: Mubbasheer Ahmed, et al.
Published: (2020-09-01)

Cardiological Monitoring – A Cornerstone for Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 Outcome: A Case Report and a Review from the Literature
by: Melit Lorena Elena, et al.
Published: (2022-11-01)

Cardiac Involvement in Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in Poland
by: Kamila M. Ludwikowska, et al.
Published: (2023-04-01)

Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19
by: Şengül Çaǧlayan, et al.
Published: (2022-08-01)

Is it all MIS-C? Unusual findings in a series of nine German patients with multi-system inflammatory syndrome in children after SARS-CoV-2 infection
by: Katrin Mehler, et al.
Published: (2021-05-01)

Anti-SARS-CoV-2 Vaccination and PIMS-TS—Friends or Foe? Case Reports and Literature Review
by: Violetta Opoka-Winiarska, et al.
Published: (2024-03-01)

Hyperinflammation in Two Severe Acute Respiratory Syndrome Coronavirus 2-Infected Adolescents Successfully Treated With the Interleukin-1 Inhibitor Anakinra and Glucocorticoids
by: Francesca I. Calò Carducci, et al.
Published: (2020-11-01)

Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwide Register
by: Magdalena Okarska-Napierała, et al.
Published: (2020-10-01)

MULTISYSTEM-INFLAMMATORY SYNDROME (MIS-C) IN NEONATE ASSOCIATED WITH SARS-COVID19
by: Yerdan Mukhaliyev, et al.
Published: (2022-06-01)